sunvozertinib
dizal pharmaceuticals
['pivotal study', 'ts,perio,0i', 'nsclc', 'pivot,io,i', 'sclc', 'ts,perio,i', 'sunvozertinib']
the first pivotal study results confirmed sunvozertinib s superior anti-tumor efficacy than the current available therapy for nsclc with egfr exon20ins. the safety profile from wu-kong6 study was consistent with previously reported findings. #meded #asco23 #asco2023 #news 
Biomedical Science that Inspires. #medicine #medtwitter #meded #Science #Research #Technology #News